Nanhua Bio Medicine Co Ltd (000504) — Cash Flow-to-Debt Ratio
Nanhua Bio Medicine Co Ltd (000504) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥22.42 Million could theoretically repay 0% of its total liabilities (CN¥479.30 Million) in one year. See how much free cash does Nanhua Bio Medicine Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanhua Bio Medicine Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Nanhua Bio Medicine Co Ltd across 28 annual periods. Also explore Nanhua Bio Medicine Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Nanhua Bio Medicine Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Nanhua Bio Medicine Co Ltd. For market capitalisation and broader financial context, see Nanhua Bio Medicine Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | CN¥-115.74 Million | CN¥634.22 Million | ▼ -1341.7% |
| 2024 | 0.01x | CN¥4.79 Million | CN¥326.17 Million | ▼ -81.1% |
| 2023 | 0.08x | CN¥36.28 Million | CN¥466.71 Million | ▼ -77.9% |
| 2022 | 0.35x | CN¥166.38 Million | CN¥473.18 Million | ▲ +80.2% |
| 2021 | 0.20x | CN¥107.10 Million | CN¥548.93 Million | ▲ +139.7% |
| 2020 | -0.49x | CN¥-207.22 Million | CN¥421.66 Million | ▼ -620.7% |
| 2019 | 0.09x | CN¥14.52 Million | CN¥153.87 Million | ▲ +246.0% |
| 2018 | -0.06x | CN¥-15.19 Million | CN¥234.95 Million | ▲ +62.3% |
| 2017 | -0.17x | CN¥-47.40 Million | CN¥276.34 Million | ▼ -160.1% |
| 2016 | -0.07x | CN¥-14.60 Million | CN¥221.43 Million | ▲ +47.3% |
| 2015 | -0.13x | CN¥-17.17 Million | CN¥137.26 Million | ▲ +61.8% |
| 2014 | -0.33x | CN¥-32.60 Million | CN¥99.61 Million | ▼ -241.0% |
| 2013 | -0.10x | CN¥-11.74 Million | CN¥122.32 Million | ▼ -117.5% |
| 2012 | -0.04x | CN¥-4.28 Million | CN¥96.86 Million | ▼ -106.5% |
| 2011 | -0.02x | CN¥-3.12 Million | CN¥146.09 Million | ▲ +95.8% |
| 2010 | -0.51x | CN¥-63.95 Million | CN¥125.69 Million | ▼ -326.2% |
| 2009 | 0.22x | CN¥60.28 Million | CN¥267.95 Million | ▲ +412.7% |
| 2008 | -0.07x | CN¥-18.59 Million | CN¥258.36 Million | ▼ -281.4% |
| 2007 | 0.04x | CN¥9.22 Million | CN¥232.31 Million | ▲ +970.8% |
| 2006 | 0.00x | CN¥717.62K | CN¥193.70 Million | ▼ -93.4% |
| 2005 | 0.06x | CN¥11.40 Million | CN¥202.16 Million | ▼ -32.2% |
| 2004 | 0.08x | CN¥13.31 Million | CN¥160.03 Million | ▼ -74.3% |
| 2003 | 0.32x | CN¥55.75 Million | CN¥172.25 Million | ▲ +375.8% |
| 2002 | 0.07x | CN¥15.83 Million | CN¥232.77 Million | ▼ -44.6% |
| 2001 | 0.12x | CN¥34.22 Million | CN¥278.69 Million | ▲ +871.8% |
| 2000 | -0.02x | CN¥-3.36 Million | CN¥211.30 Million | ▼ -151.9% |
| 1999 | -0.01x | CN¥-1.93 Million | CN¥305.96 Million | ▼ -153.0% |
| 1998 | 0.01x | CN¥3.32 Million | CN¥278.36 Million | — |